Evidence map›Paper›PMID 37542558›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2024

Functional and structural alterations in different durations of untreated illness in the frontal and parietal lobe in major depressive disorder.

Wen Liu, Xiaowei Jiang, Zijing Deng, Yu Xie, Yingrui Guo, Yifan Wu, Qikun Sun, Lingtao Kong, Feng Wu, Yanqing Tang

Open access · hybridAbstract read
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Wen LiuBrain Function Research Section, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China.
Xiaowei JiangBrain Function Research Section, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China.
Zijing DengBrain Function Research Section, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China.
Yu XieBrain Function Research Section, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China.
Yingrui GuoBrain Function Research Section, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China.
Yifan WuBrain Function Research Section, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China.
Qikun SunDepartment of Radiation Oncology, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China.
Lingtao KongBrain Function Research Section, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China.
Feng WuBrain Function Research Section, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China.
Yanqing TangDepartment of Psychiatry, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China. tangyanqing@cmu.edu.cn.
China Medical University · CNFirst Hospital of China Medical University · CN

Funding

Joint Fund of National Natural Science Foundation of China U1808204Liaoning Revitalization Talents Program XLYC1808036National Key R&D Program "Science and Technology Winter Olympics" 2021YFF0306503National Natural Science Foundation of China 82201689Natural Science Foundation of Liaoning Province 2019-MS-05Natural Science Foundation of Liaoning Province 2020-MS-176the National Key R&D Program of China 2016YFC1306900the National Key R&D Program of China Grant #2018YFC1311600
6 · The paper itself

Abstract

Major depressive disorder (MDD) is one of the most disabling illnesses that profoundly restricts psychosocial functions and impairs quality of life. However, the treatment rate of MDD is surprisingly low because the availability and acceptability of appropriate treatments are limited. Therefore, identifying whether and how treatment delay affects the brain and the initial time point of the alterations is imperative, but these changes have not been thoroughly explored. We investigated the functional and structural alterations of MDD for different durations of untreated illness (DUI) using regional homogeneity (ReHo) and voxel-based morphometry (VBM) with a sample of 125 treatment-naïve MDD patients and 100 healthy controls (HCs). The MDD patients were subgrouped based on the DUI, namely, DUI ≤ 1 M, 1 < DUI ≤ 6 M, 6 < DUI ≤ 12 M, and 12 < DUI ≤ 48 M. Subgroup comparison (MDD with different DUIs) was applied to compare ReHo and grey matter volume (GMV) extracted from clusters of regions with significant differences (the pooled MDD patients relative to HCs). Correlations and mediation effects were analysed to estimate the relationships between the functional and structural neuroimaging changes and clinical characteristics. MDD patients exhibited decreased ReHo in the left postcentral gyrus and precentral gyrus and reduced GMV in the left middle frontal gyrus and superior frontal gyrus relative to HCs. The initial functional abnormalities were detected after being untreated for 1 month, whereas this duration was 3 months for GMV reduction. Nevertheless, a transient increase in ReHo was observed after being untreated for 3 months. No significant differences were discovered between HCs and MDD patients with a DUI less than 1 month or among MDD patients with different DUIs in either ReHo or GMV. Longer DUI was related to reduced ReHo with GMV as mediator in MDD patients. We identified disassociated functional and anatomical alterations in treatment-naïve MDD patients at different time points in distinct brain regions at the early stage of the disease. Additionally, we also discovered that GMV mediated the relationship between a longer DUI and diminished ReHo in MDD patients, disclosing the latent deleterious and neuro-progressive implications of DUI on both the structure and function of the brain and indicating the necessity of early treatment of MDD.

Indexed as

Major Depressive DisorderBrainFrontal LobeGray MatterHumansMagnetic Resonance ImagingParietal LobeQuality of LifeDuration of untreated illnessGrey matter volumeMajor depressive disorderRegional homogeneityVoxel-based morphometry

Identifiers

PMID37542558
PMCPMC10995069
OpenAlexW4385597151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.